Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-24-009818
Filing Date
2024-07-15
Accepted
2024-07-15 16:35:42
Documents
15
Period of Report
2024-05-15
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A agrx-20240515x8ka.htm   iXBRL 8-K/A 35534
2 EX-10.1 agrx-20240515xex10d1.htm EX-10.1 31136
  Complete submission text file 0001558370-24-009818.txt   209409

Data Files

Seq Description Document Type Size
3 EX-101.SCH agrx-20240515.xsd EX-101.SCH 3435
4 EX-101.LAB agrx-20240515_lab.xml EX-101.LAB 18111
5 EX-101.PRE agrx-20240515_pre.xml EX-101.PRE 12479
17 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20240515x8ka_htm.xml XML 4644
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36464 | Film No.: 241117685
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)